GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice

The Journal of Clinical Investigation
D ZekzerR S Sherwin

Abstract

Although glutamic acid decarboxylase (GAD) has been implicated in IDDM, there is no direct evidence showing GAD-reactive T cells are diabetogenic in vivo. To address this issue, 3-wk-old NOD mice received two injections of purified rat brain GAD; one mouse rapidly developed diabetes 3 wk later. Splenocytes from this mouse showed a proliferative response to purified GAD, and were used to generate a CD4+ T cell line, designated 5A, that expresses TCRs encoding Vbeta2 and Vbeta12. 5A T cells exhibit a MHC restricted proliferative response to purified GAD, as well as GAD65 peptide 524-543. After antigen-specific stimulation, 5A T cells secrete IFNgamma and TNFalpha/beta, but not IL-4. They are also cytotoxic against NOD-derived hybridoma cells (expressing I-Ag7) that were transfected with rat GAD65, but not nontransfected hybridoma cells. Adoptive transfer of 5A cells into NOD/SCID mice produced insulitis in all mice. Diabetes occurred in 83% of the mice. We conclude that GAD injection in young NOD mice may, in some cases, provoke diabetes due to the activation of diabetogenic T cells reactive to GAD65 peptides. Our data provide direct evidence that GAD65 autoimmunity may be a critical event in the pathogenesis of IDDM.

References

Apr 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D EliasI R Cohen
Aug 1, 1993·Human Immunology·X M WangS Hardy
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·M SolimenaA Hayday
Nov 1, 1996·Diabetologia·K YamadaK Nonaka
Jan 7, 1997·Proceedings of the National Academy of Sciences of the United States of America·M O KurrerJ D Katz

❮ Previous
Next ❯

Citations

Mar 27, 2003·Journal of Autoimmunity·Nicoline VidebaekAnne Cooke
May 20, 2003·Journal of Autoimmunity·Gerald NepomDarcy B Wilson
May 20, 2003·Journal of Autoimmunity·Anthony Quinn
May 20, 2003·Journal of Autoimmunity·Darcy B Wilson
May 20, 2003·Journal of Autoimmunity·Gerald T Nepom
Jan 13, 2000·Current Opinion in Immunology·F S Wong, C A Janeway
Apr 21, 1999·Clinical and Experimental Immunology·E SavilahtiH K Akerblom
Sep 22, 2012·Molecular & Cellular Proteomics : MCP·Chiara ZingarettiMauro Bombaci
Feb 18, 2009·The Journal of Experimental Medicine·Cédric LouvetJeffrey A Bluestone
Nov 11, 2005·American Journal of Therapeutics·Ji-Won Yoon, Hee-Sook Jun
Nov 11, 2005·American Journal of Therapeutics·Nick Giannoukakis, Massimo Trucco
Nov 19, 2009·Regional Anesthesia and Pain Medicine·Brian A WilliamsSteven L Orebaugh
Feb 23, 2012·Cold Spring Harbor Perspectives in Medicine·Xavier Clemente-CasaresPere Santamaria
Oct 31, 1998·Immunological Reviews·J F BachP M van Endert
Jun 14, 2012·Clinical & Developmental Immunology·Greg S Gojanovich, Paul R Hess
Jun 27, 2009·The Review of Diabetic Studies : RDS·Sarah RascheAnthony Quinn
Feb 18, 2014·Cytokine & Growth Factor Reviews·Alessandro AntonelliPoupak Fallahi
Feb 7, 2014·Annual Review of Immunology·Emil R Unanue
Dec 6, 2000·Proceedings of the National Academy of Sciences of the United States of America·C P LiuW J Lin
Apr 12, 2002·Proceedings of the National Academy of Sciences of the United States of America·F Susan WongCharles A Janeway
Apr 12, 2002·Proceedings of the National Academy of Sciences of the United States of America·Hiroaki MoriyamaGeorge S Eisenbarth
Oct 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·D L RaduC A Bona
Jul 16, 2003·Proceedings of the National Academy of Sciences of the United States of America·John C Hutton, George S Eisenbarth
Sep 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Seon-Kyeong KimHugh O McDevitt
Oct 5, 2001·Journal of Neuroimmunology·I DahlmanR Weissert
Feb 26, 2003·Journal of Medical Virology·B DavydovaM Roivainen
Nov 28, 2012·La Presse médicale·Christian Boitard
Jul 13, 2002·American Journal of Medical Genetics·Hans K AkerblomMikael Knip
Jan 1, 2012·Scientifica·Christiane S Hampe
Feb 4, 2009·Journal of Autoimmunity·Yasuhiko KanazawaHiroshi Itoh
Dec 19, 2006·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Rhea Y BusickAnthony Quinn
Dec 18, 2003·Annals of the New York Academy of Sciences·Hugh McDevitt
Nov 3, 2010·Immunology·Jeffrey BabadTeresa P DiLorenzo
Jul 20, 2010·European Journal of Clinical Investigation·Harry Alexopoulos, Marinos C Dalakas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.